Important pharmacy news and late-breaking industry information updated daily.

For the first time since 2011, the American Academy of Pediatrics (AAP) has updated its guidelines on treating children and teens with ADHD—changing some criteria for diagnosis, adding current medications, and emphasizing the need to rule out other causes of symptoms. The Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents, published in the October 2019 issue of Pediatrics, emphasizes team-based care and better communication among health professionals, parents, and school staff.

HHS launched on Tuesday a program that will provide HIV prevention medications free of charge to 200,000 people without insurance. In an announcement, HHS Secretary Alex M. Azar described how the government plans to distribute the pre-exposure prophylaxis (PrEP) drugs for the Ready, Set, PrEP program.

A new study from researchers at Vanderbilt University Medical Center is adding to the growing evidence that genetic variants of the CYP2C19 enzyme can affect how PPIs are metabolized. The variations may increase the level of medication in the body and lead to more adverse reactions, specifically infections.

The prevalence of prediabetes among adolescents and young adults in the United States is high, new research shows.

Clinicians are now learning that asthma, once considered a single disease entity, is a complex inflammatory disease with multiple pathways that affect the cause and severity of the disease, according to Amber Lanae Martirosov, PharmD, BCACP, BCPS, assistant clinical professor at Wayne State University and clinical pharmacy specialist at Henry Ford Health System in Detroit.

Many common medications prescribed to older adults, including opioids, antidepressants, antacids, and sleep aids, are known to carry an increased risk of fracture. Some increase the risk of falls, others weaken bones, or do both.

Gov. Charlie Baker of Massachusetts has signed into law the nation's toughest prohibition on flavored tobacco, including a ban on menthol cigarettes. The new restrictions will put the state at the forefront of a national crackdown on flavored tobacco in an effort to stop young people from developing tobacco habits.

Federal prosecutors have reportedly opened a criminal investigation into whether pharmaceutical companies intentionally allowed opioid analgesics to flood communities. The investigation could become the largest prosecution yet of drug companies alleged to have contributed to the opioid epidemic.

FDA on Monday approved the sickle cell disease drug voxelotor (Oxbryta—Global Blood Therapeutics), adding to a new wave of treatments that promise relief from the life-threatening blood disorder that largely afflicts African-Americans.

Cynthia Knapp Dlugosz, BSPharm, NBC-HWC, has been immersed in the mindfulness community for more than 20 years, learning from some of the world’s leading mindfulness experts. Lately, her two paths—mindfulness and pharmacy—have become intertwined.